Search bioRxiv⌕ Search

Biology subjects

Mahato, A. K.

Publications and source records attributed to Mahato, A. K..

3 recordsLinked to original sources

KMT2A modulates the epigenetic landscape of rDNA by facilitating the recruitment of histone lysine acetyltransferase PCAF to the rDNA locus.

Histone acetylation is often associated with transcriptional activation across a wide range of genes, playing a key role in RNA Polymerase II dynamics. However, its specific role in transcriptional activation of RNA Polymerase I (RNA Pol I) remains unclear. In this study, we demonstrate that KMT2A associates with ribosomal DNA (rDNA) loci. Notably, the loss of KMT2A in our inducible KO cell line does not affect the levels of H3K4me3 on rDNA. We support these observations with analyses of ChIP-seq data from mouse embryonic stem cells. While H3K4 methylation remains unchanged, the absence of KMT2A causes a significant decrease in H3 acetylation levels on rDNA, especially in H3K9 acetylation levels. To identify the histone lysine acetyl transferases (KATs) that cooperate with KMT2A in promoting rDNA transcription, we examined the occupancy of multiple KATs and their associated histone acetylation marks on the rDNA locus. Our analyses identify PCAF (p300/CBP associated factor) as the KAT that contributes to KMT2A-mediated transcriptional activation of rDNA. Depletion of KMT2A reduces the levels of PCAF on rDNA, suggesting that KMT2A plays the role of a co-activator of RNA Pol I in the recruitment of KATs on the rDNA loci. Finally, the depletion of KMT2A leads to the disruption of the pre-initiation complex from the rDNA 47S promoter, resulting in a stalled RNA Pol I complex at the spacer promoter. Our findings elucidate the non-redundant, distinct function of KMT2A in the regulation of RNA Pol I transcription.

molecular biology↗

Whole genome assembly of the Little Millet (Panicum sumatrense) genome: A climate resilient crop species

Little millet (Panicum sumatrense) belongs to one of the largest genera, Panicum comprising of 500 species that are distributed especially in tropical and sub-tropical Asia as well as Africa. This is a climate resilient crop that has the ability to adapt to adverse growing conditions, especially drought. Added to this is the better nutritional profile of little millet, which has higher iron and fibre contents as compared with rice. These characteristics make it an important crop species that would be pivotal for ensuring food security. Generating genomic resources for the species is significant and will have implications in crop improvement. Therefore, in the present study we report the de novo whole genome sequence of P. sumatrense. Long read sequencing and Hi-C based scaffolding resulted in a total of 279 scaffolds with N50 of 7.8Mb. The genome was annotated to predict protein coding genes and orthologous groups were analysed after comparison with various plant genomes. This high-quality genome assembly can be a valuable resource as future reference for genomic studies in this crop and related crop species.

genomics↗

GDNF receptor agonist supports dopamine neurons in vitro and protects their function in animal model of Parkinson's disease.

Motor symptoms of Parkinsons disease (PD) are caused by degeneration and progressive loss of nigrostriatal dopamine neurons. Currently no cure for this disease is available. Existing drugs alleviate PD symptoms, but fail to halt neurodegeneration. Glial cell line-derived neurotrophic factor (GDNF) is able to protect and repair dopamine neurons in vitro and in animal models of PD, but its clinical use is complicated by pharmacokinetic properties. In the present study we demonstrate the ability of a small molecule agonist of GDNF receptor RET to support the survival of cultured dopamine neurons only when they express GDNF receptors. In addition, BT13 activates intracellular signaling cascades in vivo, stimulates release of dopamine and protect the function of dopaminergic neurons in a 6-hydroxydopamine (6-OHDA) rat model of PD. In contrast to GDNF, BT13 is able to penetrate through the blood-brain-barrier. Thus, BT13 serves as an excellent tool compound for the development of novel disease-modifying treatments against PD.

neuroscience↗